Skip to main content
BIOXYNE LIMITED logo

BIOXYNE LIMITED — Investor Relations & Filings

Ticker · BXN ISIN · AU000000BXN6 LEI · 984500F02D2B1B94E956 ASX Manufacturing
Open in API
Filings indexed 844 across all filing types
Latest filing 2003-11-25 Capital/Financing Update
Country AU Australia
Listing ASX BXN

About BIOXYNE LIMITED

https://bioxyne.com

Bioxyne Limited is a life sciences company focused on the development, manufacture, and commercialization of health and wellness products. The company specializes in proprietary probiotic strains, notably the Lactobacillus fermentum VRI-003 (PCC), which is utilized in supplements targeting immune health and gut function. Following the acquisition of Breathe Life Sciences, Bioxyne has expanded its portfolio into the medicinal cannabis sector, novel foods, and consumer health products. Its operations encompass the production and distribution of pharmaceutical-grade cannabis products, CBD-based wellness items, and functional supplements. The company serves international markets through a vertically integrated model, focusing on research-driven formulations and high-quality manufacturing standards to address growing consumer demand for therapeutic and preventative health solutions.

Recent filings

Filing Released Lang Actions
New BIF Grant 1 page ?Kb
Capital/Financing Update Classification · 95% confidence The document is a short announcement dated 26th November 2003 from VRI BioMedical regarding the award of a Biotechnology Innovation Fund (BIF) Grant. It describes the grant amount, purpose, and significance but does not contain any financial statements, detailed financial data, or comprehensive report content. The length is only 1700 characters, which is quite short and typical of a regulatory or capital/financing update announcement. The content focuses on funding received, which relates to financing activities rather than a full report or earnings release. Therefore, the document fits best under Capital/Financing Update (CAP).
2003-11-25 English
Distribution Agreement for Australia & New Zealand 2 pages ?Kb
Regulatory Filings Classification · 95% confidence The document is a company announcement dated 25th November 2003 regarding the execution of a distribution agreement for probiotic products in Australia and New Zealand. It does not contain financial data, regulatory filings, or detailed reports. It is a business update about a commercial agreement, not a financial report, management change, or shareholder meeting material. The document length is short (1915 characters) and it is an announcement of a business development. This fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous company announcements that do not fit other specific categories.
2003-11-24 English
Company Secretary Resignation 2 pages ?Kb
Board/Management Information Classification · 95% confidence The document is a short announcement dated 25th November 2003, notifying the resignation of a company secretary and the continuation of another as company secretary. It is a management-related announcement about changes in company officers but does not involve board of directors or senior management changes explicitly. The content fits best under Board/Management Information (MANG) as it relates to company secretary changes, which is a senior management role. The document is brief and does not contain financial data or other report types.
2003-11-24 English
Resignation of Director 2 pages ?Kb
Board/Management Information Classification · 100% confidence The document is a short announcement regarding the resignation of a non-executive director from the company's board. It specifically states the resignation effective date and is signed by the company secretary. There is no financial data, no mention of a report, or any other type of filing. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2003-11-16 English
Appointment of Directors & Election of Chairman 2 pages ?Kb
Board/Management Information Classification · 95% confidence The document is a company announcement dated 7th November 2003, addressed to the ASX Companies Announcements Office. It details the appointment of new directors to the Board and the election of a new Chairman. It includes biographical information about the new directors and the leadership changes. There is no financial data, no mention of financial results, no regulatory certifications, or report attachments. The content is focused solely on changes in the company's board of directors and senior management. According to the filing definitions, this fits the category 'Board/Management Information (MANG)', which covers announcements of changes in the company's board or senior management. The document length is short (2178 characters), and it is not an announcement of a report publication or a certification. Therefore, the correct classification is MANG with high confidence.
2003-11-06 English
Response to ASX Query - Appendix 4C 4 pages ?Kb
Regulatory Filings Classification · 95% confidence The document is a letter exchange between the Australian Stock Exchange (ASX) and the company VRI BioMedical Limited regarding the company's September quarter Appendix 4C report. The Appendix 4C is a quarterly cash flow report required by the ASX for listed entities. The letter addresses questions about the company's cash flow, expenses, revenues, compliance with listing rules, and future business prospects. The document does not contain the actual Appendix 4C report or detailed financial statements but is a response to ASX inquiries about the quarterly report. It is a regulatory communication related to the quarterly report but does not itself constitute a full interim or quarterly report with substantive financial data. Therefore, it fits best as a Regulatory Filing (RNS) because it is a compliance-related disclosure and response to ASX questions rather than the report itself or a financial supplement.
2003-11-04 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.